Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Low-molecular-weight antiangiogenic agent effective in mouse model of brain cancer

Oct. 2, 2003

Tarceva fails to meet primary endpoint in two phase III NSCLC trials

Oct. 2, 2003

Inex begins submission of rolling NDA for Onco TCS

Oct. 2, 2003

Final Panzem formulations selected

Oct. 2, 2003

KuDOS patent describes ATM inhibitors with potential in cancer and HIV therapy

Oct. 2, 2003

CO-501 enters clinical testing

Oct. 2, 2003

Genentech completes Avastin BLA filing

Oct. 1, 2003

Orphan drug status granted for Voraxaze

Oct. 1, 2003

Dual Tie-2/VEGFR2 inhibitors claimed by GSK researchers

Oct. 1, 2003

DNA-binding free radical scavengers with potential as chemoprotective agents

Oct. 1, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 29, 2026.
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...
GT-02897 exerts efficacy in preclinical multiple myeloma
BioWorld Science
Investigators from the Karl Landsteiner University aimed to evaluate the therapeutic potential of a novel CDK9 inhibitor/degrader, GT-02897, for the potential...